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Abstract
The agnostic screening performed by genome-wide association studies (GWAS) has uncovered associations for previously
unsuspected genes. Knowledge about the functional role of these genes is crucial and laboratory mouse models can
provide such information. Here, we describe a systematic juxtaposition of human GWAS-discovered loci versus mouse
models in order to appreciate the availability of mouse models data, to gain biological insights for the role of these genes
and to explore the extent of concordance between these two lines of evidence. We perused publicly available data (NHGRI
database for human associations and Mouse Genome Informatics database for mouse models) and employed two
alternative approaches for cross-species comparisons, phenotype- and gene-centric. A total of 293 single gene-phenotype
human associations (262 unique genes and 69 unique phenotypes) were evaluated. In the phenotype-centric approach, we
identified all mouse models and related ortholog genes for the 51 human phenotypes with a comparable phenotype in
mice. A total of 27 ortholog genes were found to be associated with the same phenotype in humans and mice, a
concordance that was significantly larger than expected by chance (p,0.001). In the gene-centric approach, we were able
to locate at least 1 knockout model for 60% of the 262 genes. The knockouts for 35% of these orthologs displayed pre- or
post-natal lethality. For the remaining non-lethal orthologs, the same organ system was involved in mice and humans in
71% of the cases (p,0.001). Our project highlights the wealth of available information from mouse models for human
GWAS, catalogues extensive information on plausible physiologic implications for many genes, provides hypothesis-
generating findings for additional GWAS analyses and documents that the concordance between human and mouse
genetic association is larger than expected by chance and can be informative.
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Introduction
Genome-wide association studies (GWAS) have led to the
discovery of hundreds of associations between genetic loci and
complex human diseases or traits [1]. These associations have very
robust statistical support, but they emerge in an agnostic fashion,
i.e. all variants are tested without considering any specific
biological rationale or prior biological evidence for the functional
importance of specific variants [2]. Discovered associations
generally represent tagging markers rather than the culprit
functional genetic variation. Therefore, once a marker is
discovered, one needs to identify what functional variation it
represents and what is the underlying biological mechanism of the
observed association [3]. Such tasks are not easy; functional
insights can be derived from new biological experiments and also,
by integration of other lines of existing biological evidence.
One of the most extensive and readily available sources of such
evidence is provided by mouse model organisms. The mouse has a
fully sequenced genome, almost all (99%) mouse genes have
orthologs in humans, and multiple tools are available for
manipulating its genome, allowing genes to be altered efficiently
and precisely. Knowledge gained from mouse models can facilitate
biomedical discoveries, by uncovering the functional role of genes
and enabling cross-species comparisons. Currently, the Mouse
Genome Informatics (MGI) database represents the most
comprehensive public resource providing integrated access to
genetic and phenotypic information for thousands of curated
mouse mutations [4].
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between gene-disease associations emerging from GWAS and
the mouse phenotypes observed when the respective gene loci are
knocked out [5,6]. However, the availability of comprehensive
databases of both mouse models and human genome-wide
associations allows a systematic effort of cross-comparisons
between these two sources of evidence and may provide some
mechanistic insights on the agnostically-derived gene-disease
associations in humans. Here, we performed such a systematic
juxtaposition of human GWAS-discovered loci versus mouse
models data. We aimed to evaluate the availability of mouse
models for human GWAS-discovered loci; record the range of
genetic and phenotypic information for these models; and explore
the extent of concordance between mouse models and human
genome-wide associations.
Materials and Methods
Genome-wide associations
We used the NHGRI catalogue of GWAS, a comprehensive
database of all published GWAS [7,8]. In order to limit our focus
to associations with robust statistical support, we extracted data on
associations with p-values ,10
28 (ref. [9]). We considered all
associations listed in the catalogue as of June 5
th, 2009. We
excluded associations where the single nucleotide polymorphisms
(SNPs) were located in gene deserts and no particular gene or set
of genes was implicated by the authors of the GWAS. We merged
entries from different GWAS where the same SNP or different
SNPs from the same gene had been associated with the same
phenotype. To avoid double-counting of findings for phenotypes
with strong biological and clinical similarity, we also merged
together similar phenotypes under a single entry. In this process,
we assessed the studied phenotypes according to the Entity-
Quality (EQ) methodology (affected entity (E) and how it is
affected (Q)) [10]. Considering the entities affected (anatomical
part, biological process, cellular component or molecular function)
in the available phenotypes, we merged phenotypic entries where
the same entity was affected. For example, for the entries
‘‘hypertension’’, ‘‘systolic blood pressure’’, ‘‘diastolic blood
pressure’’, and ‘‘blood pressure’’, we considered the same entity
–‘‘blood pressure’’– to be affected, irrespective of the exact manner
that this entity was affected (increased or decreased blood
pressure); thus all these entries were merged under the phenotype
‘‘blood pressure related phenotypes’’. By merging such similar
phenotypic entries, we obtained a final list of 69 included
phenotypes (out of the initial 102 phenotypic entries), which are
provided in Table S1.
Of the remaining, streamlined set of GWAS-discovered
associations, we selected those where only one gene had been
implicated and excluded those associations that mapped to loci
with multiple potentially implicated genes. In this selection, we
followed the arbitration of the GWAS authors and the curators of
the NHGRI catalogue. When a single gene is listed, this does not
mean that necessarily this gene is the culprit one, but the
investigators of the GWAS and the NHGRI curators considered
that the identified SNP is located in this specific gene and therefore
this gene is more likely to be the culprit than neighbouring or
distant contesters. For each one of the eligible genes, we recorded
the investigated human phenotypes and the individual GWAS
results, as provided by the NHGRI.
Mouse models
All necessary information on mouse models was extracted from
the MGI database (http://www.informatics.jax.org/) [4]: human
and mouse ortholog genes (‘‘orthologs’’) were identified through
the Mammalian Orthology section of MGI; mouse genotypic data
for each phenotype of interest were extracted by manually
searching the Mammalian Phenotype Browser and through
automated searches of the MGI Data and Statistical Reports for
Alleles and Phenotypes; mouse model and phenotypic data for all
genes of interest were extracted through manual searches in the
Genes and Markers section and through automated searches of the
Biomart system and the MGI Batch Query module. The final
searches were performed on April 22
nd, 2010 using the 4.33
release of the MGI database.
In order to search comprehensively for laboratory mouse
models for all eligible human gene-disease associations, we applied
two alternative and independent approaches: a phenotype-centric,
where our search sample was defined by the human phenotypes
studied in GWAS, and a gene-centric approach, where the search
sample was formed by the GWAS-implicated genes (Figure 1). As
described below, the information derived by these two approaches
is different and complementary. The phenotype-centric approach
is based on specific phenotypic definitions and utilizes all types of
mouse genetic models, whereas the gene-centric approach focuses
only on knockout mouse models and uses general phenotypic
descriptors (i.e. at the level of affected organ systems).
Phenotype-centric approach. In this approach, we mapped
the human phenotypes associated with GWAS-discovered loci to
their corresponding mouse phenotypes, and we assembled a
comprehensive list of mouse genes associated with these
phenotypes. Then, we evaluated the extent of overlap between
the mouse and human orthologs that have been associated with
the same phenotype (Figure 1a).
Previous work has created hierarchical systems of human
heritable phenotypes and has integrated phenotype ontologies
across species, including humans and mice [10,11,12]. However,
to our knowledge, the complex phenotypes considered in GWAS
have not been standardized in an ontology vocabulary. Thus, we
used the Mammalian Phenotype Ontology (MPO) to map the
human phenotypes to corresponding mouse (mammalian)
phenotypes [13,14]. The MPO has a hierarchical structure (tree)
from high-level, broadly descriptive terms to very low-level,
highly specific terms, presented according to the anatomical
systems affected in each condition. These systems (‘‘Anatomical
Systems Affected by Phenotypes’’) comprise a high-level phenotype
term list of organ systems (e.g., cardiovascular, digestive/
alimentary) or syndromes (e.g., life span/aging) that MGI has
phenotypes for (Table S2). In this process, we performed searches
in the MPO with the Mammalian Phenotype Browser for the
exact phenotypic terms used in the NHGRI database, supple-
mented by MeSH terms manually collected for each human
phenotype. For each human phenotypic term searched, we
examined the definitions of the retrieved mammalian phenotypes
for biological equivalency to the human ones, based on clinical
judgement and consensus among the investigators and focusing
on the Entity component of the EQ methodology. Whenever a
mammalian phenotype was considered equivalent to the human
one, we recorded the Mammalian Phenotype (MP) accession
numbers for the respective phenotype and for all lower-level
phenotypes branching out from it (descendant nodes). We also
exploited the information provided by these trees in order to
identify which anatomical systems are affected by each phenotype
and we considered the same anatomical systems to be affected in
the corresponding human phenotypes. For a subset of phenotypes
that could not be mapped to MPO based on the MeSH terms
searches, we manually screened the Mammalian Phenotype
Browser within the corresponding anatomic systems for each
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directly related to the phenotype in question. For example, for
Alzheimer’s disease, we manually screened the nervous system
phenotypes and identified two entries that corresponded to the
landmark pathology lesions of the disease: amyloid beta deposits
and neurofibrillary tangles.
In the next step, we performed systematic searches in the
‘Alleles and Phenotypes’ reports of the MGI Data and Statistical
Reports for all mouse models (considering all types of mutations,
apart from gene trapped markers that had been studied only in cell
lines and not in living organisms) associated with each MP
accession number in order to identify all mouse genes that have
been associated with each particular MP. For phenotypes with
descendant nodes, we also included the MP accession numbers of
the descendant nodes in our searches. Finally, for each phenotype,
we compared the associated human and mouse genes and we
recorded all instances where the same orthologs were associated
with the same phenotype in both species (‘‘concordant orthologs’’).
Gene-centric approach. With this second approach, our
search started from the orthologs of the GWAS-derived human
genes, for which we identified all knockout models and evaluated
their phenotypic expression (Figure 1b). Meaningful comparisons
of expressed phenotypes between human and mouse orthologs
were enabled through the following arbitrations: first, we limited
our analyses to knockout mouse models only; since the specific
genetic variants discovered in GWAS are likely tagging markers
and the causative mutations are commonly elusive, we focused
only on unambiguous mutations (complete gene deletions in
knockouts) in the mouse organisms. Furthermore, recognizing that
the specific phenotypic manifestations of gene deletion would be
expected to be qualitatively different from the phenotypic
manifestations of common genetic variations studied in human
GWAS, we limited our comparisons at the level of the anatomical
system affected.
For each ortholog of the GWAS-derived human genes, we
recorded the availability of knockout models, and we catalogued
Figure 1. Flowchart of the phenotype-centric and the gene-centric approach. MPO: Mammalian Phenotype Ontology.
doi:10.1371/journal.pone.0013782.g001
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models. The observed knockout mouse phenotypes were catego-
rized according to the anatomical system(s) affected, as described
above. In cases where a knockout model displayed lethality, this
was noted separately. For knockout models not expressing
lethality, we explored instances of phenotypic concordance (at
the level of affected anatomical system) between human gene
associations and corresponding knockouts.
Statistical analysis
For both the phenotype- and the gene-centric approach, we
compared whether the observed concordance between human and
mice data was significantly different from the expected concor-
dance by chance. The expected concordance by chance was
calculated by considering the marginal and grand totals of 262
tables with juxtaposed human and mice data.
In the phenotypic-centric approach, the expected concordance
for a given phenotype X was calculated as: [(number of mouse
genes associated with X) * (number of human genes associated
with X)/(total number of ortholog pairs with available mouse
models)]. The denominator (grand total) is approximated by the
total number of orthologous genes that have been studied in a
laboratory mouse model and thus have a chance to be associated
with the same phenotype in humans and mice. According to MGI
4.33, the denominator was set to be equal to 12,526. Then, the
expected concordances of all phenotypes were summed up and
compared to the number of overall observed concordances.
In the gene-centric approach, comparisons of phenotypic
concordance were performed at the level of the anatomical system
affected. Consequently, the expected concordance for a given gene
Y was calculated as: [(number of anatomical systems associated
with Y in mice) * (number of anatomical systems associated with Y
in humans)/(total number of anatomical systems affected in mice
and humans]. The total number of anatomical systems equals 31.
Then, the expected concordances of all genes were summed up
and compared to the number of overall observed concordances
using a chi-square test with 1 degree of freedom.
Results
A flowchart of the selection process of GWAS associations
eligible for comparisons with knockout mice models is provided in
Figure 2. Of the initial sample of 1882 SNP-phenotype
associations catalogued in the NHGRI catalogue, 735 associations
had robust statistical support (p-value,10
28). After excluding
intergenic SNPs, overlapping entries and associations involving
more than one gene, 293 gene-disease associations were eligible
for analysis pertaining to 69 different phenotypes.
Phenotype-centric approach
Of the 69 phenotypes investigated in humans, we reached
consensus on a final list of 51 phenotypes that were considered to
have a mammalian equivalent phenotype (Table S3). Forty-three
of the 51 phenotypes were mapped directly to mammalian
equivalents based on MeSH terms searches, whereas for eight
phenotypes mapping was achieved after manual searches in the
Mammalian Phenotype Browser and inferences drawn on related
pathophysiology. The remaining 18 phenotypes that could not be
Figure 2. Flowchart of the selection process of GWAS-derived gene-phenotype associations.
doi:10.1371/journal.pone.0013782.g002
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five of the 51 (49%) mammalian phenotypes included additional,
descendant phenotypic nodes, whereas the remaining ones were
lowest-level phenotypes (Tables S4 and S5). Nine mammalian
phenotypes involved two anatomical systems and the remaining
ones involved only one affected system.
Each mammalian phenotype has been associated with a median
of 21 mouse models (interquartile range (IQR), 15–61 models),
corresponding to a median of 17 different genes (IQR, 4–36) per
phenotype. In the corresponding human phenotypes, a median of
3 genes (IQR, 1–6) per phenotype was implicated in GWAS.
When comparing the orthologs involved in the human and the
mammalian phenotypes, 27 concordant orthologs were found in
10 phenotypes (Table S4). This total number of 27 concordances
between human and mice was significantly larger (p,0.001) than
the number of concordances expected by chance (expected
n=1.9). We also conducted a subgroup analysis of concordance
for phenotypes stratified by type of mapping to MPO (43
phenotypes mapped by MeSH terms and eight phenotypes
mapped by manual searches). Statistically significant concordance
was detected for both comparisons (observed vs expected
concordances =29 vs 1.8, p,0.001 and 5 vs 0.25, p,0.001,
respectively).
Although human GWAS associations have been documented in
agnostic experiments, the mouse models are typically constructed
to test a specific hypothesis, which is usually based on various types
of biological evidence. Consequently, the creation of certain
mouse models may have been informed by human genetic
associations that had already been recognized in the candidate
gene era before the advent of GWAS. In order to control for this,
we classified the human GWAS associations into novel ones and
associations proposed by candidate-gene studies (Table S6), as
previously described [15]. We then performed a sensitivity analysis
by examining only the novel GWAS associations (Table S7).
Concordance was now observed only for three phenotypes
(inflammatory bowel disease, prostate cancer, obesity-related
phenotypes) and a total of 3 genes (MST1, MSMB and SH2B1,
respectively). These gene-phenotype associations were described
by a total of 4 mouse models (MST1: 1 knockout; MSMB: 1
knock-in; SH2B1: 2 knockouts) [16,17,18,19], all of which had
been created before the publication of the GWAS that discovered
a similar association in humans. The observed concordance (n=3
genes) was only 2.5 times higher than the expected by chance
(expected n=1.17) and the difference was not nominally
significant (p=0.09). For candidate-gene study associations
though, the observed concordance (n=24 genes) was significantly
larger (p,0.001) than expected by chance (expected n=0.7).
Gene-centric approach
Our human GWAS sample of 293 gene-disease associations
involved a total of 262 unique genes, since 15 genes were
associated with more than one phenotype. Orthologs were
identified for 250 (95%) of them. We subsequently searched for
knockout mouse models constructed for these orthologs and we
were able to locate at least 1 knockout model for 150 of the 250
orthologs (60%); 73 of these orthologs had more than one
knockout model available (range 2–11). Overall, 295 knockout
models for the 150 orthologs were found in the MGI database,
with variable types of gene deletion techniques, genetic back-
grounds and phenotypic information for various allelic combina-
tions (heterozygous, homozygous, conditional genotypes etc.). All
available information on phenotypes was merged at the ortholog
gene level to allow comparisons with humans. The entire range of
phenotypic expression of each knocked out ortholog was
catalogued (Table S8).
Thirty of the 31 anatomical systems of the MPO were affected
in at least 1 knocked out ortholog. The most commonly affected
anatomical systems were the immune system, the hematopoetic
system, and homeostasis/metabolism, which were involved in
more than 40% of the examined knocked out orthologs (Figure
S1).
Fifty three of the 150 orthologs (35%) with knockout models
displayed a lethal phenotype: 34 orthologs were associated with
prenatal/perinatal lethality, 11 orthologs with postnatal lethality
and 8 orthologs with both types of lethality (Table 1 and Table
S9). Such genes may have important implications, since prenatal/
perinatal death may relate to defective embryogenesis whereas
postnatal death may signify perturbations of physiologic processes
necessary for early survival [20]. There was no evidence for
differences in the number of available knockout models for the 53
orthologs that were associated with lethality compared with the 97
non-lethal genes (median 2 [interquartile range 1 to 3] versus 1
[interquartile range 1 to 2], Mann-Whitney U test p-value=0.13),
so it is not likely that the first group had been studied far more
extensively than the latter. Notably, this proportion of the
orthologs displaying lethality (35%, [53/150]) was significantly
different from the proportion of all knocked out genes associated
with lethality in the MGI database (23% [1567/6812], p-
value=0.0006). Since knockout models for GWAS-derived genes
are more likely to express a lethal phenotype compared to mouse
models for all other genes, it is plausible that that the GWAS-
derived genes may be involved in important developmental and
physiological processes. However, given that lethality prevents the
expression of other phenotypes of interest, these 53 orthologs were
excluded from further comparisons of phenotypic expression
between humans and mice.
We subsequently compared the phenotypic expression of the
remaining 97 orthologs (i.e. those with knockout models that did not
display lethality) and the corresponding phenotypes associated with
these orthologs in the human GWAS. We restricted these
comparisonstotheaffectedanatomicalsystemlevel,thusconsidering
as agreement whenever an ortholog affected the same of the 31
anatomical systems (e.g. theESR1 gene affectedskeleton phenotypes
in both species and was thus considered as an ortholog with
concordant phenotypic information). For 69 orthologs (71%), the
same anatomical system was affected in humans and mice, and for
Table 1. Ortholog genes displaying lethality in knockout mouse models.
Prenatal/perinatal lethality Postnatal lethality Both pre- and postnatal lethality
PTCH1, STAT3, APOB, ANGPTL3, HIST1H1D, BCL11A, BMP4, JAK2, ALPL,
GATA2, HBB, HHEX, LPL, SH2B1, CYP17A1, HNF1A, HNF4A, ATG16L1, ATP2B1,
CDK6, CXCL12, KCNJ2, KIF1B, MAFB, SLC2A9, TNIP1, BRSK1, GNA12, HMGCR,
NKX2-1, SOX17, TCF7L2, HNF1B, LMTK2
HFE, TNFRSF11B, LDLR, GLIS3, INS,
TNFAIP3, FTO, NKX2-3, FOXE1, IKZF2,
LEF1
FGFR2, ABCA1, BDNF, ERBB3, GCK,
PTGER4, SMAD7, MAF
doi:10.1371/journal.pone.0013782.t001
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anatomical systems (Table S10). This total number of 82 phenotypic
concordances between humans and mice was 4.5 times higher than
the expected concordances by chance(expectedn=18.2) (p,0.001).
The immune system (n=32) and homeostasis/metabolism (n=15)
systems were the most commonly concordant systems.
In a sensitivity analysis, we considered only those orthologs for
which no prior association had been proposed with the phenotype
of interest by candidate-gene studies. There were 62 orthologs
available (Table S11) and 40 of these orthologs were associated
with the same anatomical system in humans and mice (4 orthologs
showed concordance for 2 systems). The total number of observed
concordances (n=44) was again much higher (5.2-fold higher)
than the expected number of concordant phenotypes (expected
n=8.5) (p,0.001). Concordance was still significant even when
we focused only on the 41 orthologs that had not been proposed to
be implicated in any association by candidate-gene studies
(observed vs expected concordances =27 vs 4.8, p,0.001).
Discussion
Our project represents a systematic comparison of GWAS-
derived associations in humans and corresponding information
from mouse models, based on curated and publicly available data.
We used comprehensive databases from human and mouse
research fields and we performed cross-species comparisons with
two distinct approaches [4,7]. Our findings highlighted the wealth
of genetic and phenotypic information available in mouse models
for the recently discovered genome-wide associations in humans.
The two research fields were found to provide concordant
information for certain gene-disease associations more often than
what would have been expected by chance.
This project builds on a conceptual framework of gene-disease
comparisons between different species, as developed by previous
studies. Zhang et al. [21] used advanced bioinformatic methods to
explore the extent of gene sharing between a broad range of
human and mouse model phenotypes. The recently introduced
concept of phenologs has expanded the scope of cross-species
comparisons further: capitalizing on the orthology and evolution-
ary conservation of gene-networks, novel and non-obvious models
of human disease with research utility can be uncovered [22]. Our
work diverges from the previous approaches because our
inferential target was the subset of human genetic associations
that have emerged from agnostic investigations and thus require
biological interpretation. Despite the small increments in disease
risk conferred by GWAS-discovered common variants and their
potentially limited clinical utility, we selected those variants with
robust statistical support (p,10
28), which may represent genes
with true biological implications. Moreover, there is increasing
evidence that gene loci that harbor GWAS-discovered common
variants may also harbor uncommon and rare variants and
mutations that create related disease phenotypes [23,24].
By meticulously reviewing the content of the MPO [13,14], we
were able to identify corresponding mammalian phenotypes for
the majority of the examined phenotypes in humans. Because of
the failure to a use a standard phenotype ontology for describing
GWAS data by GWAS investigators [12], we evaluated the
phenotypic matches between humans and mice based on detailed
review of the mammalian phenotypic descriptions in MPO. There
is some unavoidable subjectivity in this approach, but we decided
upfront that it would be best to carefully juxtapose phenotypic
terms and judge their similarity rather than rely on automated text
mining techniques [21]. A comprehensive and standardized
analysis of GWAS investigated phenotypes based on standardized
ontology systems would greatly facilitate future integration with
other types of experimental evidence from curated databases.
The extent of the concordant orthologs was much larger than the
expected by chance, although this difference was much attenuated
andlostnominalsignificancewhen focusingstrictlyonnovelGWAS
findings. This suggests that genes that have been identified to be
associated with various diseases and phenotypes in the candidate
gene era have been extensively and purposefully investigated in
mouse models. It is also possible that the mouse models have been
searched more stringently to identify relevant phenotypes proposed
by candidate genes. Alternatively, for agnostically discovered genes
from GWAS, there is less concordance with mouse models to-date.
Nevertheless,concordanceat thegene-levelmayunderestimate true
biological similarity between species. Although the specific sets of
genes associated with the same phenotype in humans and mice may
be different, these genes may operate within networks that
determine the same biological function. Such similarities can
potentially be demonstrated by future analyses that use molecular
pathway ontology systems for the genes of interest, e.g. Gene
Ontology.Thus,theorthologsfoundinouranalysestobeassociated
with the examined phenotypes in mice only can further inform
secondary analyses (either gene-focused or pathway-based) of
existing datasets in humans [25].
In the gene-centric approach, we found that for the majority of
the GWAS-derived genes, there are already available knockout
models with deposited phenotypic information in MGI. We
catalogued this phenotypic information and found extensive
concordance between humans and mice, showing that certain
orthologs can affect the same anatomical systems, and potentially
the same biological function in both species. The concordance was
still present when we excluded candidate-era genes.
This significant concordance is striking in view of the vast
differences in the underlying genetic variants compared between
humans and mice. In the GWAS, most of the associations for the
common variants are likely due to variations altering gene function
in relatively subtle ways. In contrast, knockout mouse models
involve complete ablation of gene function, abolishing any activity
of the corresponding protein. Furthermore, certain gene deletions
were lethal in mice and thus were excluded from analyses. Despite
these factors, we observed that the same anatomical systems were
commonly affected in the two species; thus, our estimates of
concordance may under-represent the true biological similarity
that underlies the genetic associations in humans and mice.
The common variants studied in GWAS genotyping chips may
tag rare variants that constitute the molecular basis of the observed
associations [26]; rare variants could display more profound
phenotypic effects and possibly affect the same mechanisms as the
ones severely perturbed in knockout models. Moreover, common
and uncommon variants affecting the same or similar phenotypes
at different levels may coexist on the same gene and confer
independent risks [23,24]. Consequently, the comparisons be-
tween diametrically different mutational loads in humans and mice
have meaningful biologic rationale.
Although phenotypes in many mouse models may not be
agnostically or comprehensively ascertained [27], these expressed
phenotypes can provide a plausible range of biological functions
for the unknown mechanisms of the human GWAS-derived genes.
Our database can also provide hints for secondary-hypotheses
analyses in GWAS datasets and possible new discoveries, by
examining the phenotypes observed in mice for certain orthologs.
Deletion of GWAS orthologs in knockout mice was more often
associated with lethal phenotypes compared to other genes in the
MGI database. Such orthologs may have important developmen-
tal and physiological implications. This observation shows that
Mouse Models for GWAS Hits
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uncover important and previously unknown biology. Finally, 100
of the 250 (40%) GWAS-implicated orthologs were lacking a
knockout model. Our project highlights these 100 orthologs as a
subset of genes that may merit priority by laboratory mouse
investigators for creation of knockout models.
Translation of GWAS discoveries into clinically meaningful
diagnostic and therapeutic modalities will require an understand-
ing of the underlying biology [2]. Our analyses showed that pre-
existing mouse genetic models provide a wealth of analyzable
information for the majority of human phenotypes studied and
genes discovered in GWAS. We also found that significant
concordance beyond chance between humans and mice exists.
Current analyses are nevertheless limited by the fact that mouse
phenotypic ascertainment is commonly narrow-scope and focused
on prior biological hypotheses. Conversely, a significant minority
of valid GWAS associations do not currently have any available
genetically-modified mouse models for further investigation, a
situation that can be expected to become more common as the
number of GWAS-discovered genes increases. Ongoing interna-
tional efforts, such as the Knockout Mouse Project [27], aim to
create a comprehensive repository of knockouts for all mouse
genes, with standardized phenotypic screens and publicly available
information. Convergence of genomic data from different research
venues [21,22,28] has the potential to drive new discoveries, to
inform the pathophysiology of genetic associations and to
accelerate the clinical translation of genomic applications.
Supporting Information
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